Incidence, Demographics, and Clinical Characteristics of Diabetes of the Exocrine Pancreas (Type 3c): A Retrospective Cohort Study
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
OBJECTIVE This study was conducted to describe the incidence of diabetes following pancreatic disease, assess how these patients are classified by clinicians, and compare clinical characteristics with type 1 and type 2 diabetes. RESEARCH DESIGN AND METHODS Primary care records in England (n = 2,360,631) were searched for incident cases of adult-onset diabetes between 1 January 2005 and 31 March 2016. We examined demographics, diabetes classification, glycemic control, and insulin use in those with and without pancreatic disease (subcategorized into acute pancreatitis or chronic pancreatic disease) before diabetes diagnosis. Regression analysis was used to control for baseline potential risk factors for poor glycemic control (HbA1c ≥7% [53 mmol/mol]) and insulin requirement. RESULTS We identified 31,789 new diagnoses of adult-onset diabetes. Diabetes following pancreatic disease (2.59 [95% CI 2.38–2.81] per 100,000 person-years) was more common than type 1 diabetes (1.64 [1.47–1.82]; P < 0.001). The 559 cases of diabetes following pancreatic disease were mostly classified by clinicians as type 2 diabetes (87.8%) and uncommonly as diabetes of the exocrine pancreas (2.7%). Diabetes following pancreatic disease was diagnosed at a median age of 59 years and BMI of 29.2 kg/m2. Diabetes following pancreatic disease was associated with poor glycemic control (adjusted odds ratio, 1.7 [1.3–2.2]; P < 0.001) compared with type 2 diabetes. Insulin use within 5 years was 4.1% (3.8–4.4) with type 2 diabetes, 20.9% (14.6–28.9) with diabetes following acute pancreatitis, and 45.8% (34.2–57.9) with diabetes following chronic pancreatic disease. CONCLUSIONS Diabetes of the exocrine pancreas is frequently labeled type 2 diabetes but has worse glycemic control and a markedly greater requirement for insulin.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A distinguishing feature is concurrent pancreatic exocrine insuf fi ciency (consider screening individuals with acute and chronic pancreatitis for exocrine pancreatic insuf fi ciency by measuring fecal elastase), pathological pancreatic imaging (endoscopic ultrasound, MRI, and computed tomography), and absence of type 1 diabetes -associated autoimmunity (116 -120).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [117]
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181 · cited 1×
“diabetes without preceding pancreatic disease, diabetes after acute pancreatitis, and diabetes after chronic pancreatic disease (27).”
BackgroundRegression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Proportional hazards tests and diagnostics based on weighted residuals
GRAMBSCH, P. M., & THERNEAU, T. M. (1994) · Biometrika · doi:10.1093/biomet/81.3.515 · Cited by 5,885 · cited 1×
“We initially created Cox proportional hazards models to assess the hazard of progression to insulin; however, these failed proportional hazards testing (28,29).”
MethodInzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015) · Diabetes Care · doi:10.2337/dc14-2441 · Cited by 3,066 · cited 1×
“control as HbA1c $7% (53 mmol/mol), according to the generic target of the American Diabetes Association and the European Association for the Study of Diabetes hyperglycemia guidelines (24).”
MethodThe Regression Analysis of Binary Sequences
Cox, D. R. (1958) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1958.tb00292.x · Cited by 2,813 · cited 1×
“We created logistic regression models for odds of poor glycemic control at 1 year and at 5 years (26).”
MethodType 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer
Hart, P. A., Bellin, M. D., Andersen, D. K., Bradley, D., Cruz-Monserrate, Z., Forsmark, C. E., Goodarzi, M. O., Habtezion, A., Korc, M., Kudva, Y. C., et al. (2016) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30106-6 · Cited by 551
Natural Course in Chronic Pancreatitis
Lankisch, P. G., Löhr-Happe, A., Otto, J., & Creutzfeldt, W. (1993) · Digestion · doi:10.1159/000201029 · Cited by 452 · cited 1×
“This form of diabetes results when a process, such as inflammation, neoplasia, or surgical resection, disrupts the global architecture or physiology of the pancreas, often resulting in both exocrine and endocrine dysfunction (2,3).”
BackgroundNewly diagnosed diabetes mellitus after acute pancreatitis: a systematic review and meta-analysis
Das, S. L. M., Singh, P. P., Phillips, A. R. J., Murphy, R., Windsor, J. A., & Petrov, M. S. (2014) · Gut · doi:10.1136/gutjnl-2013-305062 · Cited by 401 · cited 1×
“sulin if monitored beyond 5 years (17).”
Cited by
Items 101–200 of 284
Lv, Y., Lu, X., Liu, G., Qi, L., Zhong, Z., Wang, X., Zhang, W., Shi, R., Goodarzi, M. O., Pandol, S. J., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae080 · Cited by 17
Shivaprasad, C., Kolly, A., Aiswarya, Y., Atluri, S., Rakesh, B., Anupam, B., & Amit, G. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.03.003 · Cited by 15
Qi, L., Wei, Q., Ni, M., Liu, D., Bao, J., Lv, Y., Xia, H., Wang, Q., Wang, L., Su, J., et al. (2021) · Diabetes & Metabolism · doi:10.1016/j.diabet.2021.101316 · Cited by 15
Norbitt, C. F., Kimita, W., Bharmal, S. H., Ko, J., & Petrov, M. S. (2022) · Nutrients · doi:10.3390/nu14071480 · Cited by 17
“New-onset prediabetes/diabetes after AP (NODAP) develops in about 40% of individuals after an episode of AP and individuals with NODAP are characterised by chronic low-grade inflammation, impaired lipid metabolism, iron metabolism, and islet dysfunction [17,21,22].”
BackgroundDyson, N. J., Kattner, N., Al-Selwi, Y., Honkanen‐Scott, M., Shaw, M. F., Brack, C. A., Coulthard, R., Flaxman, C. S., Richardson, S. J., & Shaw, J. (2025) · Diabetologia · doi:10.1007/s00125-025-06547-8 · Cited by 21
“Type 3c diabetes secondary to chronic pancreatitis and associated with pancreatic fibrosis is often mis-classified as type 2 diabetes [33].”
Hodzic-Santor, B. H., Colacci, M., Raissi, A., Ray, P., Verma, A. A., Razak, F. A., MacFadden, D. R., Biering‐Sørensen, T., Skaarup, K. G., Sarma, S., et al. (2024) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2024.01.006 · Cited by 14
Impact of Serum Glucose Levels on Outcomes in Acute Pancreatitis: A Retrospective Analysis
Balaban, M., Balaban, D. V., Enache, I., Nedelcu, I. C., Jinga, M., & Gheorghe, C. (2024) · Medicina · doi:10.3390/medicina60060856 · Cited by 14
“Our study could have benefitted from a correlation of the obtained results with the patients’ body mass indexes (BMIs), but data regarding BMIs were not available in the medical records of all patients.”
ResultBhat, J. A., Bhat, M. H., Misgar, R. A., Bashir, M., Wani, A. I., Masoodi, S., Ashraf, H., & Sood, M. (2019) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_297_19 · Cited by 14
Diabetes as a consequence of acute pancreatitis
Charley, E. L., Dinner, B. A., Pham, K., & Vyas, N. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i31.4736 · Cited by 14
Imaging abnormalities of the pancreas in diabetes: implications for diagnosis and treatment
Spilseth, B., Fogel, E. L., Toledo, F. G. S., & Campbell‐Thompson, M. (2024) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000001054 · Cited by 16
Paramythiotis, D., Karlafti, E., Tsavdaris, D., Giakoustidis, A. E., Panidis, S., Ioannidis, A., Prassopoulos, P. K., & Michalopoulos, A. (2024) · Medicina · doi:10.3390/medicina60101592 · Cited by 13
Hopkins, R., Young, K., Thomas, N. J., Jones, A. G., Hattersley, A. T., Shields, B. M., Dennis, J., & McGovern, A. P. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16163 · Cited by 16
“9 In the absence of universally accepted diagnostic criteria, we adopted a similar pragmatic approach to previous observational studies of type 3c diabetes and classified people based on prior records of a pancreatic condition.”
InfluentialSelf-citationValdez-Hernández, P., Pérez-Díaz, I., Soriano-Rios, A., Gómez-Islas, V., García-Fong, K. R., Hernández-Calleros, J., Uscanga-Dominguez, L., & Pelaez-Luna, M. (2021) · Pancreas · doi:10.1097/mpa.0000000000001930 · Cited by 14
van Wilpe, R., Hulst, A. H., Siegelaar, S. E., DeVries, J. H., Preckel, B., & Hermanides, J. (2022) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2022.111012 · Cited by 16
Jiménez‐Luna, C., Martín-Blázquez, A., Diéguez-Castillo, C., Díaz, C., Jl, M., Genilloud, O., Vicente, F., del Palacio, J. P., Prados, J. C., & Caba, O. (2020) · Metabolites · doi:10.3390/metabo10110423 · Cited by 13
Amyloidogenesis of feline amylin and plasma levels in cats with diabetes mellitus or pancreatitis
Jotha-Mattos, L., Vieira, A. B., Castelo, M. D. S. M., Queiroz, A., de Souza, H. J. M., de Alencar, N. X., & Lima, L. M. T. R. (2020) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2020.106532 · Cited by 16
“Recently, human pancreatitis has been associated with the decrease in b-cell function in a progression rate even higher than in type 2 diabetes mellitus [21].”
BackgroundJawahar, A. P., Narayanan, S., Loganathan, G., Pradeep, J., Vitale, G. C., Jones, C. M., Hughes, M. G., Williams, S. K., & Balamurugan, A. N. (2018) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x13666180918092729 · Cited by 13
Modesto, A. E., Ko, J., Stuart, C. E., Bharmal, S. H., Cho, J., & Petrov, M. S. (2020) · Diseases · doi:10.3390/diseases8030025 · Cited by 13
“A four-year follow-up study found an increase in lean mass in individuals with new-onset prediabetes and diabetes compared with normoglycemia individuals [50], whereas a six-year follow-up study observed a decrease in skeletal muscle mass in elderly T2DM individuals compared with normoglycemia individuals [51].”
BackgroundInfluentialOlesen, S. S., Hagn-Meincke, R., Drewes, A. M., Steinkohl, E., & Frøkjær, J. B. (2020) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2020.1867891 · Cited by 13
“These patients may have type 2 diabetes, which is much more prevalent than PPDM [3].”
BackgroundLi, X., Kimita, W., Cho, J., Ko, J., Bharmal, S. H., & Petrov, M. S. (2021) · Nutrients · doi:10.3390/nu13041112 · Cited by 14
“8% at five years after diabetes diagnosis when compared with individuals with Type 2 diabetes [6].”
BackgroundTissue-Specific Alteration of Metabolic Pathways Influences Glycemic RegulationPreprint
Ng, N. H. J., Willems, S. M., Fernandez, J., Fine, R. S., Wheeler, E., Wessel, J., Kitajima, H., Marenne, G., Rundle, J. K., Sim, X., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/790618 · Cited by 13
Type 3c diabetes associated with chronic pancreatitis: A narrative review
Rasheed, A., Galande, S., Farheen, S., Sasikala, M., Reddy, D. N., & Talukdar, R. (2025) · Pancreatology · doi:10.1016/j.pan.2025.08.005 · Cited by 17
Approach to the Patient With Pancreatogenic Diabetes
Ode, K. L., Imai, Y., & Norris, A. W. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf623 · Cited by 13
Infante, M., & Ricordi, C. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2168645 · Cited by 11
“Although dwarfed by T2DM, DEP represents the second most common type of new-onset diabetes mellitus in adults (surpassing T1DM) [2,5].”
BackgroundResultDiabetes mellitus as a consequence of acute severe pancreatitis: Unraveling the mystery
Manrai, M., Singh, A. K., Birda, C. L., Shah, J., Dutta, A., Bhadada, S. K., & Kochhar, R. K. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i8.1212 · Cited by 12
Risk Factors and Mechanisms for Diabetes in Pancreatitis
Villasmil, M. G. P., & Bellin, M. D. (2024) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2024.08.002 · Cited by 15
Associations of Habitual Mineral Intake with New-Onset Prediabetes/Diabetes after Acute Pancreatitis
Norbitt, C. F., Kimita, W., Ko, J., Bharmal, S. H., & Petrov, M. S. (2021) · Nutrients · doi:10.3390/nu13113978 · Cited by 11
“Due to these established differences between the types of diabetes, treating new-onset diabetes after acute pancreatitis as type 2 diabetes is detrimental to optimal management [1,5,12].”
BackgroundMastracci, T. L., Apte, M. V., Amundadottir, L. T., Alvarsson, A., Artandi, S. E., Bellin, M. D., Bernal‐Mizrachi, E., Caicedo, A., Campbell‐Thompson, M., Cruz‐Monserrate, Z., et al. (2022) · Pancreas · doi:10.1097/mpa.0000000000002170 · Cited by 15
Novel diabetes subgroups – Authors' reply
Ahlqvist, E., Prasad, R. B., Tuomilehto, J., Rosengren, A. H., & Groop, L. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30139-6 · Cited by 10
Association of pancreatitis with risk of diabetes: analysis of real-world data
Ba, D. M., Chinchilli, V. M., Cozzi, A. M., Bradley, D. P., & Pichardo-Lowden, A. R. (2024) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2023.1326239 · Cited by 10
“It is likely the most common complication after AP or CP, with a cumulative incidence ranging from 23% to 40% (8 – 10).”
BackgroundResultKimita, W., Bharmal, S. H., Ko, J., Cho, J., & Petrov, M. S. (2021) · Food & Function · doi:10.1039/d1fo00729g · Cited by 10
Assessment of insulin sensitivity and secretion in patients with fibrocalculous pancreatic diabetes
Aiswarya, Y., Shivaprasad, C., Kolly, A., Atluri, S., Anupam, B., & Goel, A. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s204254 · Cited by 12
“Diabetes of the exocrine pancreas (DEP) is far more common than previously recognized and accounts for 1–5% of all cases of diabetes.(1,2) Chronic pancreatitis (CP) and pancreatic neoplasia are the two most common causes of DEP.”
BackgroundEpidemiology and management of atopic dermatitis in England: an observational cohort study protocol
de Lusignan, S., Alexander, H., Broderick, C., Dennis, J., McGovern, A. P., Feeney, C., & Flohr, C. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-037518 · Cited by 9
Self-citationBharmal, S. H., Kimita, W., Ko, J., & Petrov, M. S. (2021) · Endocrine Connections · doi:10.1530/ec-21-0229 · Cited by 9
“Several recent population-based studies showed that the age-specific risk of post-pancreatitis diabetes mellitus is the highest among young adults with AP (6, 47, 48, 49).”
BackgroundDítě, P., Bojková, M., Bělobrádková, J., Žák, P., & Kianička, B. (2022) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-4744 · Cited by 10
“So far, the terms secondary pancreatic diabetes [2] and diabetes of the exocrine pancreas (DEP) [3] – as a synonym for the two above-mentioned terms – have still been used.”
BackgroundA Systematic Mapping Study on the Risk Factors Leading to Type II Diabetes Mellitus
Musafer, K. N. J., Huyop, F., Ewadh, M., Supriyanto, E., & Rava, M. (2020) · Karbala International Journal of Modern Science · doi:10.33640/2405-609x.1677 · Cited by 10
Bengtsen, M. B., & Møller, N. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac123 · Cited by 9
“In addition, it is becoming increasingly clear that a substantial proportion of individuals with diabetes exhibit exocrine pancreatic dysfunction and reduced pancreatic volume [60]; conversely, “pancreatic/type 3c” diabetes secondary to exocrine pancreatic disease is relatively common in adults and often misdiagnosed…”
BackgroundChowdhury, A. S., Palui, R., Pramanik, S., & Mondal, S. (2024) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2024.103100 · Cited by 8
Wan, X., Wang, Y., Liu, Z., Liu, Z., Zhong, S., & Huang, X. (2025) · Scientific Reports · doi:10.1038/s41598-025-86290-7 · Cited by 10
Cost-Effectiveness of Biomarker-Associated Early Pancreatic Cancer Detection in New-Onset Diabetes
Stefanova, I., Thompson, N., Oldfield, L. S., Stott, M. C., Hanson, R., Palmer, D. H., Halloran, C. M., Greenhalf, W., Meer, R. V. D., & Costello, E. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.38031 · Cited by 7
Claridge, H., Price, C. A., Ali, R., Cooke, E. A., de Lusignan, S., Harvey-Sullivan, A., Hodges, C., Khalaf, N. I., O’Callaghan, D., Stunt, A., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-079863 · Cited by 8
Post-pancreatitis diabetes mellitus: towards understanding the role of gastrointestinal motility
Gold-Smith, F. D., Chand, S. K., & Petrov, M. S. (2018) · Minerva Gastroenterologica e Dietologica · doi:10.23736/s1121-421x.18.02507-2 · Cited by 7
Impact of stress hyperglycemia on long-term prognosis in acute pancreatitis without diabetes
Zhang, J., Wang, X., Lv, Y., Hou, J., Zhang, C., Su, X., & Li, L. (2024) · Internal and Emergency Medicine · doi:10.1007/s11739-023-03524-0 · Cited by 9
“Compared with type 2 diabetes, post-pancreatic diabetes is associated with poorer glycemic control and a higher risk of mortality [25, 26], which carries a heavy burden on human health and the economy.”
The prevalence and impact of low faecal elastase-1 in community-based patients with type 2 diabetes
Riceman, M. D., Bound, M. J., Grivell, J., Hatzinikolas, S., Piotto, S., Nguyen, N. Q., Jones, K. L., Horowitz, M., Rayner, C. K., & Phillips, L. K. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107822 · Cited by 7
Guo, S.-Y., Yang, H.-Y., Ning, X.-Y., Guo, W.-W., Chen, X., & Xiong, M. (2022) · Pancreas · doi:10.1097/mpa.0000000000002025 · Cited by 8
Kattner, N., Bashir, A., & Shaw, J. A. M. (2026) · Diabetologia · doi:10.1007/s00125-026-06678-6 · Cited by 8
“In a large retrospective study of UK primary healthcare records, type 3c diabetes was more prevalent than type 1 diabetes, affecting 1.8% vs 1.1% of the studied population [11].”
InfluentialVisceral Fat Predicts New-Onset Diabetes After Necrotizing Pancreatitis
Trikudanathan, G., Abdallah, M., Munigala, S., Vantanasiri, K., Jonason, D. E., Faizi, N. A., Schat, R., Chauhan, A., Freeman, M. L., & Bellin, M. D. (2024) · Pancreas · doi:10.1097/mpa.0000000000002292 · Cited by 6
Biochemical pathways involved in diabetes mellitus
Molehin, O. R., Fakayode, A. E., Olaoye, A. B., Teibo, J. O., & Adeola, O. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13195-0.00005-3 · Cited by 8
Exocrine pancreatic inflammation in canine diabetes mellitus – An active offender?
Johnson‐Pitt, A., Catchpole, B., & Davison, L. J. (2024) · The Veterinary Journal · doi:10.1016/j.tvjl.2024.106241 · Cited by 8
Lanzinger, S., Karges, W., Merger, S. R., Laimer, M. W., Lück, U., Wagner, C., Milek, K., & Holl, R. W. (2020) · Pancreatology · doi:10.1016/j.pan.2020.05.023 · Cited by 7
Pancreatogenic Diabetes Mellitus: Endocrinologist’s and Gastroenterologist’s Point of View
Tarasova, Z. S., Bordin, D. S., Kileynikov, D. V., & Kucheryavy, Y. A. (2020) · Effective Pharmacotherapy · doi:10.33978/2307-3586-2020-16-15-92-100 · Cited by 10
Shesternikova, O. P., Финн, В. К., Lesko, K. A., & Винокурова, Л. В. (2023) · Automatic Documentation and Mathematical Linguistics · doi:10.3103/s0005105523020085 · Cited by 6
“…of severe life-threatening conditions: damage to the kidneys, eyes and the musculoskeletal, cardiovascular, and central nervous systems, as well as an increased mortality rate of the working population from diseases and pathological conditions such as myocardial infarction and stroke [11].”
BackgroundLi, X., & Petrov, M. S. (2024) · Nutrients · doi:10.3390/nu16030435 · Cited by 7
“…to use insulin therapy 1 year after the diabetes diagnosis, and 5.2 times more likely 5 years after the diabetes diagnosis, after adjustment for common covariates (i.e., age, sex, ethnicity, alcohol consumption, smoking status, body mass index, and initial haemoglobin level at diagnosis) [129].”
BackgroundMethodInfluentialThe Diagnosis and Management of Atypical Types of Diabetes
Kreider, K. E. (2018) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2018.09.022 · Cited by 9
Huan, C., Stanek, A., Mueller, C. M., Ou, P., Dong, S., Zhang, J. H., Abdelnaby, R., & Gruessner, R. W. G. (2019) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2019.02.005 · Cited by 9
Kimita, W., Bharmal, S. H., Ko, J., Cho, J., & Petrov, M. S. (2021) · Nutrients · doi:10.3390/nu13103557 · Cited by 6
“There is ample evidence that individuals with NODAP are at a higher risk of mortality [60], morbidities (including pancreatic cancer [61]), have poorer glycaemic control [62], differing gut hormone responses [47], and have different risks of mortality related to the use of antidiabetic medications [63,64]”
BackgroundFeher, M. D., Munro, N. M., Russell-Jones, D. L., de Lusignan, S., & Khunti, K. K. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30126-8 · Cited by 6
Self-citationBa, D. M., Hart, P. A., Qiu, T., Krishna, S. G., Gao, X., LESLIE, D. L., Bradley, D. P., Maranki, J. L., Fofana, K., Chinchilli, V. M., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1704688 · Cited by 5
Sherchan, A., Jin, F., Sherchan, B., Mandal, S. K., Regmi, B. U., Ghising, R., Upadhaya, S. R., Gautam, B., Pathak, D., & Li, M. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1551926 · Cited by 5
Lanzinger, S., Welters, A., Thon, A., Konrad, K., Kapellen, T. M., Grulich‐Henn, J., Raddatz, D., & Holl, R. W. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12894 · Cited by 5
“was lower compared to the reported prevalence in adult patients with pancreatic diabetes.(2,3) We observed large differences between the”
ResultNavasardyan, L. V., Furlan, I., Brandt, S., Schulz, A., Wabitsch, M., & Denzer, C. (2023) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-023-01501-z · Cited by 5
“Other pathways for the development of dysglyce-mia have been described in other exocrine pancreatic diseases due to pancreatic inflammation or absolute loss of pancreatic alpha-and beta-cells, hypothetically comparable to SDS [34].”
BackgroundGalantamine ameliorates experimental pancreatitis
Thompson, D., Tsaava, T., Rishi, A., George, S. J., Hepler, T. D., Hide, D., Pavlov, V. A., Brines, M. L., Chavan, S. S., & Tracey, K. J. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00746-y · Cited by 5
“Therefore, study of galantamine in a model of repeated acute pancreatitis will be needed to evaluate its potential as a therapeutic to prevent the complications of chronic pancreatitis, such as exocrine insufficiency (Rijk et al. 2022) and diabetes (Woodmansey et al. 2017).”
BackgroundKaleru, T., Vankeshwaram, V., Maheshwary, A., Mohite, D., & Khan, S. (2020) · Cureus · doi:10.7759/cureus.8884 · Cited by 11
Dunning, T. L. (2018) · SM Gerontology and Geriatric Research · doi:10.36876/smggr.1011 · Cited by 6
Kempeneers, M. A., Issa, Y., Ali, U. A., Bruno, M. J., van Geenen, E. J. M., van Hooft, J. E., Römkens, T. E. H., Siersema, P. D., Spanier, B. W. M., Yahya, I., et al. (2021) · Pancreas · doi:10.1097/mpa.0000000000001937 · Cited by 4
Healthcare disparities in pancreatitis: knowledge gaps and next steps
Choate, R., Bradley, D. P., Conwell, D. L., & Yazıcı, C. (2024) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000001058 · Cited by 5
Bellin, M. D., Andersen, D. K., Akshintala, V. S., Born, D., Coghill, R. C., Easler, J. J., Fogel, E. L., Forsmark, C. E., Freeman, A. J., Hughes, S. J., et al. (2024) · Pancreas · doi:10.1097/mpa.0000000000002403 · Cited by 4
Groove Pancreatitis in Focus: Tumor-Mimicking Phenotype, Diagnosis, and Management Insights
Balaban, M., Balaban, D. V., Mănucu, G., Bucurica, S., Costache, R. S., Radu, F. I., Jinga, M., & Gheorghe, C. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14051627 · Cited by 4
“Exocrine pancreatic insufficiency (EPI) in GP can be attributed to the inflammation extending to the pancreatic head and papillary area, which can obstruct normal enzyme secretion.”
Type 1 Diabetes Autoantibodies in Acute, Recurrent Acute, and Chronic Pancreatitis
Wasserfall, C. H., Forsmark, C. E., Li, S., Li, L., Hart, P. A., Goodarzi, M. O., Kudva, Y. C., Bellin, M. D., Yadav, D. K., Conwell, D. L., et al. (2025) · Diabetes · doi:10.2337/db24-0931 · Cited by 6
Pancreatic Cancer and Diabetes: Insights, Hypotheses, and Next Steps
Hill, J. L. E., Hill, T. G., Parslow, D. S., & Hill, D. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110245 · Cited by 6
Hart, P. A., Andersen, D. K., Bellin, M. D., Kudva, Y. C., Toledo, F. G. S., Goodarzi, M. O., Basina, M., Cusi, K. J., Fisher, W., Fogel, E. L., et al. (2026) · Pancreatology · doi:10.1016/j.pan.2026.04.001 · Cited by 5
Hinton, W., Feher, M. D., Munro, N. M., & de Lusignan, S. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0390-8 · Cited by 4
“We have also previously demonstrated our ability to compare real-world and trial use of another class of medication in diabetes [20], and also to link complex data, in this example pancreatitis, to cases of diabetes [21].”
BackgroundSelf-citationMehra, A., Mittal, A., & Vishwakarma, P. K. (2024) · Current Drug Metabolism · doi:10.2174/0113892002321919240801065905 · Cited by 4
Less common types of diabetes mellitus: Incidence and glucose control in the perioperative setting
van Wilpe, R., Hulst, A. H., Polderman, J. A. W., Hollmann, M. W., DeVries, J. H., Preckel, B., & Hermanides, J. (2021) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2021.110460 · Cited by 4
Choi, J. H., Paik, W. H., Jang, D. K., Kim, M. K., Ryu, J. K., Kim, Y., Han, K., & Lee, S. H. (2022) · Cancers · doi:10.3390/cancers14225696 · Cited by 4
Soytürk, M., Bengı, G., Oğuz, D., Kalkan, İ. H., Yalnız, M., Tahtacı, M., Demır, K., Kasap, E., Oruç, N., Ünal, N. G., et al. (2020) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2020.220920 · Cited by 9
Ortiz, J., Ghazalli, N., Lopez, K., Rawson, J., McCown, E. M., Oh, E., Irimia, J. M., Jou, K., Mares, J., Chen, M.-H., et al. (2024) · Diabetes · doi:10.2337/db23-0490 · Cited by 3
The need for life-long holistic follow-up after pancreaticoduodenectomy
Phillips, M., Pinn, G., Karanjia, N. D., Kumar, R., Frampton, A. E., & Hart, K. H. (2025) · Digestive and Liver Disease · doi:10.1016/j.dld.2025.07.017 · Cited by 5
Tao, L. V., Karasinska, J. M., Souza, V. G. P., Loree, J. M., Johnson, J. D., Renouf, D. J., & Schaeffer, D. F. (2026) · Frontiers in Gastroenterology · doi:10.3389/fgstr.2025.1645459 · Cited by 6
Ha, K. H., Park, M., Lee, Y., Kim, D. J., & Han, S. J. (2025) · Diabetes & Metabolism · doi:10.1016/j.diabet.2025.101668 · Cited by 3
Diabetes mellitus tipo 3c secundaria a pancreatitis crónica: reporte de un caso
Universidad César Vallejo, F. D. C. M. T., Deza, C. M. G., López, J. G. C., Universidad Nacional de Trujillo. Trujillo, P., Ríos, E. D. S. G., & Universidad César Vallejo, F. D. C. M. T. (2020) · Horizonte Médico (Lima) · doi:10.24265/horizmed.2021.v21n1.12 · Cited by 7
“Si bien la DM3c tiene características que se superponen con la DM1 y la DM2, es clínica y metabólicamente distinta de ambas (tablas 1 y 2), con características únicas y prioridades de manejo específicas que requieren una terapia personalizada.”
BackgroundInfluentialLa diabetes tipo 3c. Abordaje desde el médico del primer nivel
Díaz, M. S., Unanua, M. P. P., Martínez, I. P., Serrano, A., & Rodríguez, J. C. A. (2023) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2023.102074 · Cited by 5
Diabetic keto-acidosis in pancreatic diabetes – how is it different from DKA in type 1 or type 2 DM?
Mondal, S., Dasgupta, R., Lodh, M., Parida, A. K., Haldar, M., & Ganguly, A. (2023) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-023-01244-x · Cited by 3
“This was inclusive of tropical calcific pancreatitis (also known as fibrocalculous pancrea-topathy), alcohol-induced chronic pancreatitis, autoimmune pancreatitis, and hereditary pancreatitis [12].”
Epidemiology of post-pancreatitis diabetes mellitus: insights from the COSMOS program
Cho, J., & Petrov, M. S. (2024) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2024.2382958 · Cited by 4
“A 2017 historical cohort study using primary care data of over two million individuals from the United Kingdom reported that DEP was misclassified as T2DM in 88% of the people [23].”
InfluentialAcute Abdomen in Diabetic Patients - What Should We Do?
Doran, H., & Pătraşcu, T. (2018) · Chirurgia · doi:10.21614/chirurgia.113.5.593 · Cited by 3
“Some papers also named it “diabetes following pancreatic disease” or “diabetes of the exocrine pancreas” and found out that it is frequently labeled as type 2 diabetes, but has worse glycemic control and a markedly greater insulin requirement (21).”
Osher, E., Geva, R., Wolf, I., Tordjman, K. M., Klausner, J. M., Sofer, Y., Scapa, E. F., Shibolet, O., Shor, D. B., Bar-Yishay, I., et al. (2023) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2023.100322 · Cited by 6
“Conversely, it can be hypothesized that pancreatic adenocarcinoma and PNETs contribute to the development of DM by disruption of pancreatic architecture, secondary to tumor growth, and by the adjacent inflammation, resulting in combined exocrine and endocrine dysfunction, a condition classified by the American Diabete…”
BackgroundWang, Y., Zhou, Q., Zhang, L., Dai, Y., Huang, Z., Zhang, H., & Yi, B. (2019) · Hormone and Metabolic Research · doi:10.1055/a-0955-6563 · Cited by 3
“Studies have shown that many special types of diabetes are associated with insulin secretion dysfunction and pancreatic dysplasia [1], such as type 3c diabetes that is caused by pancreatic disease [2].”
BackgroundCefalu, W. T., Andersen, D. K., Arreaza-Rubín, G., Pin, C. L., Sato, S. M., Verchere, C. B., Woo, M., Rosenblum, N. D., Rosenblum, N. D., Cefalu, W. T., et al. (2021) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2021.09.126 · Cited by 10
Diabetes Mellitus Secondary to Chronic Pancreatitis: Aspects of Clinical Course and Management
As, A., Moscow, R. F., Pashkova, E. Y., Amikishieva, K. A., & Рамазанович, Г. В. (2023) · Doctor Ru · doi:10.31550/1727-2378-2023-22-4-59-63 · Cited by 2
Balaban, M., Balaban, D. V., Enache, I., Nedelcu, I. C., Jinga, M., & Gheorghe, C. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14144932 · Cited by 2
“AP is the leading pancreatic condition associated with the onset of type 3c diabetes mellitus (T3cDM) [4,5]—a secondary form of diabetes caused by exocrine pancreatic dysfunction—through mechanisms such as islet cell destruction due to inflammation and necrosis, altered insulin signaling [6],…”
Tang, L. L., Zhang, Q. L., Song, S., Liu, N., Du, Q. L., Zhong, S. T., & Huang, X. (2025) · Insights into Imaging · doi:10.1186/s13244-025-02039-w · Cited by 2
Early mechanisms of diabetes development in pediatric pancreatitis: A pilot study
Villasmil, M. G. P., Bellin, M. D., Pinnaro, C. T., Craighead, F., Cress, G. A., Uç, A., Lowe, M. E., Hodges, J. S., & Ode, K. L. (2025) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/jpn3.70263 · Cited by 2
Qian, S., Liu, Y., Wang, W., Ni, W.-J., Zhao, S., Xu, Y., Gu, P., Yu, W., & Tong, Z. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1501530 · Cited by 2
Predicting New-onset Diabetes Following Acute Pancreatitis: The CAPS Score
Trieu, H., Chowdhury, A. R., Dodge, J. L., Hiramoto, B. A., Alas, B. F., Wang, S., Wang, D., Nguyen, D. D., Tarakji, A., Sumethasorn, M., et al. (2025) · Pancreas · doi:10.1097/mpa.0000000000002571 · Cited by 2
Hong, G., Elangovan, A., Harper, E., Perez, J. A., Culp, S., Shah, H., Park, E., Burlen, J., Swei, E., Devore, Z., et al. (2026) · Pancreatology · doi:10.1016/j.pan.2026.02.004 · Cited by 2
Complications of Pancreatitis—Knowledge Gaps and Research Opportunities: A Workshop Summary
Saloman, J. L., Andersen, D. K., Abu‐El‐Haija, M. A., Bellin, M. D., Conwell, D. L., Faghih, M., Forsmark, C. E., Goodarzi, M. O., Gulla, A., Hart, P. A., et al. (2026) · Pancreas · doi:10.1097/mpa.0000000000002574 · Cited by 2
Can Persistent Children Hyperglycemia Be Induced by Causes Other Than Pancreas Failure?
Assis, A. S. D., & Nobrega, J. L. P. D. (2022) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2022.127011 · Cited by 2
Newman, D., Warren, B., Barker, R. B., Wykoff, C. C., & Vujosevic, S. (2024) · Ophthalmology and Therapy · doi:10.1007/s40123-024-01053-3 · Cited by 2
Sherif, A. E., McFadyen, R., Boyd, J. A., Ventre, C., Glenwright, M., Walker, K., Zheng, X., White, A. C., McFadyen, L., Connon, E., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-040200 · Cited by 2
de Lusignan, S., Hobbs, R. F., Liyanage, H., Sherlock, J., Ferreira, F. M., Tripathy, M., Heiß, C., Feher, M. D., & Joy, M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265998 · Cited by 2
“Historically it has largely been involved in the monitoring of infectious disease [19, 20] but since 2015 has been involved in a wider range of research including AF, [21] diabetes, [22] and cancer [23].”
Background
Metadata
- Authors
- Woodmansey, C., McGovern, A. P., McCullough, K. A., Whyte, M. B., Munro, N. M., Correa, A. C., Gatenby, P. A. C., Jones, S. A., & de Lusignan, S.
- Affiliations
- University of Surrey (GB)
- Royal Surrey County Hospital (GB)
- Department of Clinical and Experimental Medicine, University of Surrey, Guildford, Surrey, U.K.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2017-08-31
- Volume
- 40
- Issue
- 11
- Pages
- 1486-1493
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2752023293
- Cited by
- 280
- References
- 36
- Citations by year
- 2026: 26 · 2025: 28 · 2024: 36 · 2023: 33 · 2022: 38 · 2021: 34 · 2020: 29 · 2019: 28 · 2018: 25 · 2017: 3
- FWCI
- 23.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Surrey Research Insight Open Access (The University of Surrey) (submittedVersion)
- Funders
- National Institute for Health and Care Research (ACF-2017-23-003)
- Topics
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 3c diabetes, type 2 diabetes, incidence, acute pancreatitis, chronic pancreatitis, glycemic control, insulin requirement, HbA1c, primary care records
- MeSH terms
- Acute Disease, Adult, Aged, Aged, 80 and over, Blood Glucose, Chronic Disease, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, England, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Hyperglycemia, Insulin, Male, Middle Aged, Pancreatitis, Primary Health Care, Retrospective Studies, Risk Factors, Body Mass Index, Incidence, Pancreas, Exocrine, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.